MXPA05009656A - Regimenes contraceptivos transdermicos extendidos. - Google Patents
Regimenes contraceptivos transdermicos extendidos.Info
- Publication number
- MXPA05009656A MXPA05009656A MXPA05009656A MXPA05009656A MXPA05009656A MX PA05009656 A MXPA05009656 A MX PA05009656A MX PA05009656 A MXPA05009656 A MX PA05009656A MX PA05009656 A MXPA05009656 A MX PA05009656A MX PA05009656 A MXPA05009656 A MX PA05009656A
- Authority
- MX
- Mexico
- Prior art keywords
- cycle
- progestogen
- contraception
- days
- estrogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Se describe un metodo de contracepcion que comprende el paso de administrar a una mujer que menstrua un ciclo de terapia contraceptiva, dicho ciclo de terapia incluyendo, por cuando menos 42 dias sucesivos, la administracion de una combinacion de un estrogeno y un progestageno en una dosificacion diaria contraceptivamente efectiva, en donde dicho progestageno es un progestageno inhibidor de sulfatasa potente, y dicho ciclo de terapia incluye 4 a 8 dias que estan libres de la administracion de estrogeno, despues de dichos por lo menos 42 dias sucesivos; se describe tambien un metodo de contracepcion, que provee control mejorado del sangrado y continuacion e indices de satisfaccion mejorados en mujeres que menstruan usando el metodo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/385,597 US20030219471A1 (en) | 2002-03-11 | 2003-03-11 | Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens |
| PCT/US2003/023134 WO2004080442A1 (en) | 2003-03-11 | 2003-07-24 | Extended transdermal contraceptive regimens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05009656A true MXPA05009656A (es) | 2006-03-08 |
Family
ID=32987305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05009656A MXPA05009656A (es) | 2003-03-11 | 2003-07-24 | Regimenes contraceptivos transdermicos extendidos. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030219471A1 (es) |
| EP (1) | EP1613293A1 (es) |
| KR (1) | KR20070006543A (es) |
| CN (1) | CN1771024A (es) |
| AU (1) | AU2003252139A1 (es) |
| BR (1) | BR0318192A (es) |
| CA (1) | CA2517778A1 (es) |
| CR (1) | CR8010A (es) |
| EC (1) | ECSP056009A (es) |
| MX (1) | MXPA05009656A (es) |
| RU (1) | RU2005128284A (es) |
| WO (1) | WO2004080442A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| EP1453521B1 (en) | 2001-12-05 | 2013-09-04 | Teva Women's Health, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| EP1624848A4 (en) | 2003-05-02 | 2009-02-25 | Duramed Pharmaceuticals Inc | METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE |
| US7816546B2 (en) * | 2003-06-30 | 2010-10-19 | Richter Gedeon Vegyeszeti Gyar Rt. | Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime |
| ZA200600201B (en) | 2003-07-16 | 2008-07-30 | Duramed Pharmaceuticals Inc | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
| TW200626161A (en) * | 2004-10-07 | 2006-08-01 | Duramed Pharmaceuticals Inc | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
| US8063030B2 (en) * | 2006-03-02 | 2011-11-22 | Warner Chilcott Company, Llc | Extended cycle multiphasic oral contraceptive method |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3545397A (en) * | 1969-03-17 | 1970-12-08 | Dowty Technical Dev Ltd | Air-cushion vehicles and like craft |
| IL48277A (en) * | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
| US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
| US5188835A (en) * | 1986-06-16 | 1993-02-23 | Kabi Pharmacia Ab | Intravaginal devices |
| SE8602666D0 (sv) * | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
| US4906463A (en) * | 1986-12-22 | 1990-03-06 | Cygnus Research Corporation | Transdermal drug-delivery composition |
| US5006342A (en) * | 1986-12-22 | 1991-04-09 | Cygnus Corporation | Resilient transdermal drug delivery device |
| US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5252334A (en) * | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
| DE4344463A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
| ATE229828T1 (de) * | 1995-06-07 | 2003-01-15 | Ortho Mcneil Pharm Inc | Transdermales pflaster zur verabreichung von 17- deacetyl norgestimat alleine oder in kombination mit einem östrogen |
| CN1652796A (zh) * | 2002-03-11 | 2005-08-10 | 詹森药业有限公司 | 使用***和抑制硫酸酯酶的孕激素的长周期避孕给药方案 |
-
2003
- 2003-03-11 US US10/385,597 patent/US20030219471A1/en not_active Abandoned
- 2003-07-24 WO PCT/US2003/023134 patent/WO2004080442A1/en not_active Application Discontinuation
- 2003-07-24 BR BRPI0318192-8A patent/BR0318192A/pt not_active IP Right Cessation
- 2003-07-24 MX MXPA05009656A patent/MXPA05009656A/es unknown
- 2003-07-24 RU RU2005128284/14A patent/RU2005128284A/ru not_active Application Discontinuation
- 2003-07-24 EP EP03816278A patent/EP1613293A1/en not_active Withdrawn
- 2003-07-24 CA CA002517778A patent/CA2517778A1/en not_active Abandoned
- 2003-07-24 KR KR1020057016954A patent/KR20070006543A/ko not_active Application Discontinuation
- 2003-07-24 CN CNA038264390A patent/CN1771024A/zh active Pending
- 2003-07-24 AU AU2003252139A patent/AU2003252139A1/en not_active Abandoned
-
2005
- 2005-09-08 EC EC2005006009A patent/ECSP056009A/es unknown
- 2005-09-28 CR CR8010A patent/CR8010A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004080442A1 (en) | 2004-09-23 |
| CR8010A (es) | 2009-01-16 |
| EP1613293A1 (en) | 2006-01-11 |
| ECSP056009A (es) | 2006-07-28 |
| RU2005128284A (ru) | 2006-02-10 |
| CA2517778A1 (en) | 2004-09-23 |
| US20030219471A1 (en) | 2003-11-27 |
| KR20070006543A (ko) | 2007-01-11 |
| CN1771024A (zh) | 2006-05-10 |
| BR0318192A (pt) | 2006-03-21 |
| AU2003252139A1 (en) | 2004-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1070003A1 (en) | Continuous sulfatase inhibiting progestogen hormone replacement therapy | |
| TW200626161A (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
| PL323729A1 (en) | Skin sticking plaster and method of administering sole 17-deacetyl norgestimate or together with estrogen | |
| NZ545130A (en) | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration | |
| HK1019305A1 (en) | Progestogen-anti-progestogen regimens | |
| MX2009004616A (es) | Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente. | |
| CY1105276T1 (el) | Τριφασικο στοματικο αντισυλληπτικο | |
| WO2002051420A3 (en) | Methods and formulations for the treatment of female sexual dysfunction | |
| PL327182A1 (en) | Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor | |
| NZ503890A (en) | Oral contraceptives comprising non-uterotrophic anti-estrogens and progestin | |
| WO2004098517A8 (en) | Methods of hormonal treatment utilizing extended cycle contraceptive regimens | |
| NZ333750A (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| NZ591627A (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
| ECSP056009A (es) | Regimenes contraceptivos transdermicos extendidos | |
| BG101427A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
| NZ504351A (en) | Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen | |
| NO974255L (no) | Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner | |
| 陆仁康 et al. | Inhibition of Ovulation in Women by Intranasal Treatment with Luteinizing Hormone Releasing Hormone Agonist | |
| UA38479A (uk) | Спосіб моделювання остеопорозу |